Ligand validation:6ZGP

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZGP_EPE_E_404	13%	20%	0.254	0.792	1.21	2.15	1	5	1	0	100%	1
6ZGP_EPE_A_404	10%	29%	0.292	0.796	1	1.81	1	5	0	0	100%	1
6ZGP_EPE_C_404	5%	23%	0.377	0.773	1.35	1.81	1	4	0	0	100%	1
6ZGP_EPE_I_404	4%	29%	0.367	0.762	1.03	1.81	1	6	0	0	100%	1
6ZGP_EPE_K_404	4%	27%	0.348	0.72	1.29	1.63	1	3	0	0	100%	1
6ZGP_EPE_H_404	3%	19%	0.429	0.76	1.39	2.06	1	4	0	0	100%	1
6ZGP_EPE_B_404	2%	28%	0.435	0.718	1.17	1.71	1	6	1	0	100%	1
6ZGP_EPE_L_404	2%	27%	0.467	0.735	1.05	1.86	1	4	2	0	100%	1
6ZGP_EPE_F_404	2%	20%	0.445	0.711	1.23	2.16	1	6	2	0	100%	1
6ZGP_EPE_G_404	2%	21%	0.386	0.633	1.27	2.02	1	5	1	0	100%	1
6ZGP_EPE_J_404	2%	25%	0.456	0.694	1.24	1.81	1	5	0	0	100%	1
6ZGP_EPE_D_404	1%	31%	0.467	0.65	1.19	1.56	1	4	0	0	100%	1
6Y9D_EPE_A_405	4%	15%	0.257	0.634	2.23	1.54	1	4	0	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	26%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.